Jesteś tu:
>
>
>
>
>
Nowe metody terapii cukrzycy – insulina wziewna
Nowe metody terapii cukrzycy – insulina wziewna
Dr n. med. Marek Derkacz, lek. Iwona Perzyńska
Piśmiennictwo
1. Gaensslen M. Ueber Inhalation von Insulin. Klin Wochenschr 1925; 4: 71-72
2. Patton J., Bukar J., Eldon M. Clinical Pharmacokinetics and Pharmacdynamics of Inhaled Insulin. Clin. Pharmacokinet. 2004; 43 (12): 781-801
3. Skyler J., Cefalu W., Kourides I. i wsp. Efficacy of inhaled human insulin in type 1 diabetes mellitus: A randomised proof-of-concept study. Lancet. 2001; 357: 331-335
4. Heise T., Rave K., Bott S., i wsp. Time-action profile of an inhaled insulin preparation in comparison to insulin lisipro and regular insulin [abstract]. Diabetes 2000 ; 49 Suppl. 1:A 10
5. Brunner G., Balent B., Ellmerer M. i wsp. Dose-response relation of liquid aerosol inhaled insulin in type I diabetic patients. Diabetologia. 2001; 44(3): 305-308
6. Ellis SL, Gemperline KA, Garg SK. Review of Phase 2 Studies Utilizing the AIR® Particle Technology in the delivery of Human Insulin Inhalation Powder Versus Subcutaneous Regular or Lispro Insulin in Subjects with Type 1 or Type 2 Diabetes. Diabetes Technol Ther. 2007; 9(s1): S48-56
7. De Galan BE, Simsek S, Tack CJ, Heine RJ. Efficacy and safety of inhaled insulin in the treatment of diabetes mellitus. Neth J Med. 2006; 64(9): 319-325
8. Richardson PC, Boss AH. Technosphere insulin technology. Diabetes Technol Ther. 2007; 9(s1) :S65-72
9. Exubera package insert. New York , NY: Pfizer Labs;2006 May
10. Patton JS, Bukar J, Nagarajan S. Inhaled insulin. Adv Drug Deliv Rev. 1999; 35(2-3): 235-247
11. Barnett AH, Dreyer M, Lange P, Serdarevic-Pehar M. An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with metformin as adjunctive therapy ina patients with type 2 diabetes poorly controlled on a sulfonylurea. Diabetes Care. 2006; 29(6): 1282-1287
12. Newhouse M. Tennis anyone?The lungs as a new court for systemic therapy.CMAJ 1999;161:1287-1288
13. Cappelleri JC, Cefalu WT, Rosenstock J, Kourides IA, Gerber RA. Treatment satisfaction in type 2 diabetes: a comparison between an inhaled insulin regimen and subcutaneous insulin regimen. Clin Ther.2002; 24(4); 552-564
14. Guntur VP, Dhand R. Inhaled insulin: extending the horizons of inhalation therapy. Respir Care. 2007; 52(7): 911-922
15. Henry R., Mudaliar S., Howland III W. i wsp. Inhaled insulin using the AERx insulin diabetes management system in healthy and asthmatic subjects. Diabetes Care. 2003; 26(3): 764-769
16. Rave K, de la Pena A, Tibaldi FS, Zhang L, Silverman B, Hausmann M, Heinemann L, Muchmore DB
17. AIR inhaled insulin in subjects with chronic obstructive pulmonary disease: pharmacokinetics, glucodynamics, safety, and tolerability.Diabetes Care. 2007 Jul;30(7):1777-82
18. Mudaliar S, Henry RR. Inhaled insulin in patients with asthma and chronic obstructive pulmonary disease
19. Diabetes Technol Ther. 2007 Jun;9 Suppl 1:S83-92.
20. Gern JE, Stone CK, Nakano M, Muchmore DB, de la Pena A, Park S, Suri A, Tibaldi F, Soon D, Busse WW. Effect of Upper Respiratory Tract Infection on AIR Inhaled Insulin Pharmacokinetics and Glucodynamics in Healthy Subjects. Clin Pharmacol Ther. 2007 Jul 11; [Epub ahead of print]
21. Kohler D. Aerosois for systemic treatment. Lung 1990;168(suppl): 677-684
22. Departament of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research Endocrinologic and Metabolic Drugs Advisory Committee. www.fda.gov/ohrms/dockets/ac/05/transcripts/2005-4169T1.pdf Transcript of the meeting of Thursday,September 8,2005
23. Himmelmann A., Jendle J., Mellen A., Petersen A., Dahl U., Wollmer P. The impact of smoking on inhaled insulin. Diabetes Care. 2003; 26(3): 677-682
24. Facchini F., Hollenbeck C., Jeppesen J, Chen YDI, Reaven G. Insulin resistance and cigarette smoking. Lancet. 1992; 339: 1128–1130
25. Attvall S., Fowelin J., Lager I., Von Schenk H., Smith U. Smoking induces insulin resistance: a potential link with the insulin resistance syndrome. J Intern Med. 1993; 233: 327–332
26. Targher G., Alberiche M., Zenere M., Bonadonna R., Muggeo M., Bonora E. Cigarette smoking and insulin resistance in patients with non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab. 1997; 82: 3619–3624.
27. Becker RH, Sha S, Frick AD, Fountaine RJ. The effect of smoking cessation and subsequent resumption on absorption of inhaled insulin.Diabetes Care. 2006 Feb;29(2):277-82.
28. Quattrin T., Belanger A., Bohannon N., Schwartz S. Exubera Phase III Study Group.
Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial. Diabetes Care. 2004; 27(11): 2622-2627
29. Royle P, Waugh N, McAuley L, McIntyre L, Thomas S. inhaled insulin in diabetes mellitus. Cochrane database Syst Rev. 2004; (3): CD003890
30. Ceglia L, Lau J, Pittas AG. Meta-analysis: efficacy and safety of inhaled insulin therapy in adults with diabetes mellitus.Ann Intern Med. 2006 Nov 7;145(9):665-75.
31. Barnett AH, Bellary S. Inhaled human insulin (Exubera): clinical profile and patient considerations Vasc Health Risk Manag. 2007;3(1):83-91.
32. Fineberg S., Kawabata T., Finco-Kent D., Liu C., Krasner A. Antibody Response to Inhaled Insulin in Patients with Type 1 or Type 2 Diabetes. J Clin Endocrinol Metab.
33. 2005; 90(6): 3287-3294
34. Leslie CC, McCormick-Shannon K, Robinson PC, Mason RJ. Stimulation of DNA synthesis in cultured ratn alveolar type II cells.Exp Lung Res 1985;8:5666
35. Iida K, Suzuki H, Sone H, et al. Insulin inhibits apoptosis of macrophage cell line, THP-1 cells, via phosphatidylinositol-3-kinase-dependent pathway. Arterioscler Thromb Vasc Biol 2002;22:380-386
36. Chailler P., Briere N. Insulin alters cell proliferation during the early development of rodent kidney. Cell Biol Int Rep. 1991; 15(10): 955-963
37. Menard D., Corriveau L., Beaulieu J. Insulin modulates cellular proliferation in developing human jejunum and colon. Biol Neonate. 1999; 75(3): 143-151

diabeTECH
Nota prawnaPolityka prywatnościRedakcja serwisuKontakt z redakcjąMapa serwisuZgłoś uwagi